https://orcid.org/0000-0002-1930-9660
Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Gary H. Lyman. (2023) Perception, Cognition and Thought: Part I Nature, Evolution and Development of Conceptual and Symbolic Processes. Cancer Investigation 41:6, pages 535-538.
Read now
Read now
Gary H. Lyman, Pavlos Msaouel & Nicole M. Kuderer. (2023) Risk Model Development and Validation in Clinical Oncology: Lessons Learned. Cancer Investigation 41:1, pages 1-11.
Read now
Read now
Pavlos Msaouel. (2022) The Big Data Paradox in Clinical Practice. Cancer Investigation 40:7, pages 567-576.
Read now
Read now
Vicente Valentí, Paula Jiménez-Fonseca, Pavlos Msaouel, Ramón Salazar & Alberto Carmona-Bayonas. (2022) Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit. Cancer Investigation 40:2, pages 184-188.
Read now
Read now
Articles from other publishers (5)
Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Virginia Arrazubi, Diego Cacho Lavin, Raquel Hernandez San Gil, Ana Custodio, Juana María Cano, Ana Fernández Montes, Oriol Mirallas, Ismael Macias Declara, Rosario Vidal Tocino, Laura Visa, María Luisa Limón, Paola Pimentel, Nieves Martínez Lago, Tamara Sauri, Marta Martín Richard, Monserrat Mangas, Mireia Gil Raga, Aitana Calvo, Pablo Reguera, Mónica Granja, Alfonso Martín Carnicero, Carolina Hernández Pérez, Paula Cerdá, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Vilma Pacheco Barcia, David Gutierrez Abad, Maribel Ruiz Martín, Jamie Weaver, Wasat Mansoor & Javier Gallego. (2023) The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy. Therapeutic Advances in Medical Oncology 15, pages 175883592311576.
Crossref
Crossref
Sena Valcarcel, Javier Gallego, Paula Jimenez-Fonseca, Marc Diez, Eva Martínez de Castro, Raquel Hernandez, Virginia Arrazubi, Ana Custodio, Juana María Cano, Ana Fernández Montes, Ismael Macias, Laura Visa, Aitana Calvo, Rosario Vidal Tocino, Nieves Martínez Lago, María Luisa Limón, Mónica Granja, Mireia Gil, Paola Pimentel, Lola Macia-Rivas, Carolina Hernández Pérez, Montserrat Mangas, Alfonso Martín Carnicero, Paula Cerdà, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Mª Dolores Mediano Rambla, Marta Martin Richard & Alberto Carmona-Bayonas. (2022) Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry. Journal of Cancer Research and Clinical Oncology.
Crossref
Crossref
Pavlos Msaouel, Juhee Lee, Jose A. Karam & Peter F. Thall. (2022) A Causal Framework for Making Individualized Treatment Decisions in Oncology. Cancers 14:16, pages 3923.
Crossref
Crossref
J. Gallego Plazas, A. Arias-Martinez, A. Lecumberri, E. Martínez de Castro, A. Custodio, J.M. Cano, R. Hernandez, A.F. Montes, I. Macias, A. Pieras-Lopez, M. Diez, L. Visa, R.V. Tocino, N. Martínez Lago, M.L. Limón, M. Gil, P. Pimentel, M. Mangas, M. Granja, A.M. Carnicero, C. Hernández Pérez, L.G. Gonzalez, P. Jimenez-Fonseca & A. Carmona-Bayonas. (2022) Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry. ESMO Open 7:3, pages 100514.
Crossref
Crossref
Andrew W. Hahn, Nazli Dizman & Pavlos Msaouel. (2022) Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive. Therapeutic Advances in Medical Oncology 14, pages 175883592211031.
Crossref
Crossref